FDA Orders Review of Painkiller Data, Issues Cox-2 Advisory
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
403479
US health regulators have warned of heart risks connected to over-the-counter painkiller naproxen, creating additional confusion over the safety of similar drugs after recent warnings for two other painkillers.
652888
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month's worldwide withdrawal of Merck & Co Inc.'s Vioxx.
272490
The US Food and Drug Administration is recommending physicians limit prescriptions for popular painkillers known as Cox-2 inhibitors after recent studies suggested they may increase the risk of heart attacks and strokes.
373977
Two studies released yesterday have turned up new evidence that all of the popular arthritis painkillers known as cox-2 inhibitors may put users at greater risk of heart attacks and strokes.
905
Two leading heart experts called for  urgent investigations on Wednesday into whether all painkilling  drugs known as COX-2 inhibitors may raise the risk of heart  attack in some people.
369115
The European Commission has ordered a  full-scale probe into the safety of five remaining Cox-2  arthritis drugs, following last month's worldwide withdrawal of  Merck & Co Inc.'s Vioxx.
105508
Two leading heart experts called for urgent investigations on Wednesday into whether all painkilling drugs known as COX-2 inhibitors may raise the risk of heart attack in some people.
60804
Two years after the withdrawal of the painkiller Vioxx, a dysfunctional Food and Drug Administration still can't adequately track the safety of new drugs and respond quickly to problems, a panel of experts said Friday.
364747
THURSDAY, Dec. 23 (HealthDayNews) --  The U.S. Food and Drug Administration says it will review all prevention trials involving the prescription pain medications Celebrex and Bextra. These drugs are part of a category of drugs known as Cox-2 inhibitors.
170971
U.S. health officials on Tuesday proposed new warnings about liver and stomach risks on the labels of over-the-counter pain relievers such as aspirin, ibuprofen and acetaminophen.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
286900
The US Food and Drug Administration says it plans to convene a panel of experts in February to discuss the safety of painkillers in the same class as the now-withdrawn drug Vioxx, but one member of the panel was asked not to come.
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
79247
Merck &amp; Co., which withdrew the Vioxx painkiller last month because of a heart risk, said yesterday that US regulators have asked for more safety data before they will approve the medicine&#39;s successor, Arcoxia.